Lilly (LLY), Boehringer Ingelheim Report Linagliptin plus ACE/ARB Post-Hoc on UACR Hits Primary Endpoint

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/20/2026

1. TGT
2. EL
3. SPY
4. BILL
5. WMT
6. ADI
7. ROST
8. MRK
9. MRNA
10. LOW

Go back to Lilly (LLY), Boehringer Ingelheim Report Linagliptin plus ACE/ARB Post-Hoc on UACR Hits Primary Endpoint
Lilly (Eli) & Co. (NYSE: LLY) Delayed: 1244.40 -35.94 (2.81%)
Previous Close $1280.34    52 Week High $88.16 
Open $1274.13    52 Week Low $67.88 
Day High $1280.28    P/E 288.06 
Day Low $1243.23    EPS $4.32 
Volume 2,317,861